This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
LORAZEPAM SUBLINGUAL
AA PHARMA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of LORAZEPAM SUBLINGUAL in Canada?
A shortage of LORAZEPAM SUBLINGUAL 1MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 20, 2026), but it has not started yet.
Why is LORAZEPAM SUBLINGUAL not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will LORAZEPAM SUBLINGUAL be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02410753
Strength
1MG
Dosage Form
TABLET
Route
SUBLINGUAL
Active Ingredient
LORAZEPAM
Tier
Unrated
Last Updated
2026-08-27
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
LORAZEPAM SUBLINGUAL has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from AA PHARMA INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
10MG · DIN 02420333
DIN 00784400
DIN 02248764
DIN 02248763
50MG · DIN 02458748
200MG · DIN 02458756
25MG · DIN 02248034
100MG · DIN 02248035
30MG · DIN 00771376
60MG · DIN 00771384
67MG · DIN 02243180
200MG · DIN 02239864